Epidermolysis Bullosa
Epidermolysis Bullosa Awareness Week: Achieving Positive Change Through Treatment Innovations and Emerging Therapies
This Epidermolysis Bullosa (EB) Awareness Week, we reflect on the
October 22, 2025
This Epidermolysis Bullosa (EB) Awareness Week, we reflect on the
Safe, effective, compassionate care — it’s what every patient deserves,
This PA Week 2025, we celebrate the remarkable role and
Atopic Dermatitis (AD) remains the most prevalent dermatologic condition in
The U.S. Food and Drug Administration (FDA) recently expanded the
In May 2023, the FDA approved beremagene geperpavec (B-VEC, Vyjuvek®),
World Atopic Eczema Day and National Atopic Eczema Week shine
As dermatology and aesthetic professionals, you know that healthy skin
Messenger RNA (mRNA) technology gained prominence during the COVID-19 pandemic,
The rise of GLP-1 receptor agonists has transformed not only
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
